Omega-3 EPA/DHA
Vitafusion Omega-3 EPA/DHA is an omega and fish oil supplement provided in gummy form, containing 7 ingredients per 2-gummy serving. This product includes an Omega Fatty Acid Blend of 300 mg and notably provides Vitamin A at 500 IU, which is considered to be at a clinical dose. However, other vitamins such as Vitamin C (6 mg), Vitamin D (200 IU), and Vitamin E (3 IU) are underdosed. The product holds an N+ Score of 44 and an 'F' grade, indicating a below-average quality assessment due to the significant underdosing of several key vitamins. It may be suitable for those seeking a convenient source of some omega fatty acids and a clinical dose of Vitamin A, but not for comprehensive vitamin support.
About This Product
Omega-3 EPA/DHA by Vitafusion is a omega & fish oil supplement containing 7 active ingredients. It has earned an N+ Score of 44/100 (Grade F).
Notable clinical-dose ingredients include Vitamin A.
N+ Score Breakdown
Are key ingredients present at clinically effective doses based on research?
Does the product include all expected ingredients for its supplement category?
Are individual ingredient amounts clearly disclosed without proprietary blends?
Does the formula include a breadth of beneficial compounds from multiple pathways?
Strengths
- +Fully transparent label with individual ingredient amounts disclosed
- +Broad ingredient diversity exceeding category norms
- +1 ingredient(s) at clinical dose levels
Weaknesses
- −Several ingredients below clinically effective doses
- −Missing several expected ingredients for its category
Ingredient Analysis (7 ingredients)
| Ingredient | Amount | Dose Adequacy |
|---|---|---|
| Calories | 20.000 Calorie(s) | N/A |
| Vitamin A | 500.000 IU | Adequate |
| Vitamin C | 6.000 mg | Under |
| Vitamin D | 200.000 IU | Under |
| Vitamin E | 3.000 IU | Under |
| Total Carbohydrates | 4.000 Gram(s) | N/A |
| Omega Fatty Acid Blend | 300.000 mg | N/A |
Clinical ranges based on NIH ODS Fact Sheets and peer-reviewed research. Status indicates whether the amount meets evidence-based thresholds.